One Group, two strategies

Following the Galenica Group’s consistent and successful implementation of its transformation strategy since 1995, the Board of Directors concluded that the Group was ready to prepare a new phase. In August 2014, a new management structure with two CEOs was introduced to enable the different business models of Vifor Pharma and Galenica Santé to evolve in an even more focused way, taking into account their individual growth dynamics. The management structure was adjusted accordingly and organisational changes implemented just a few weeks later.

Medium- to long-term vision: two listed, independent companies

In December 2015, the Board of Directors concluded that the preconditions for dividing the Group in the fourth quarter of 2016 had been met, provided the economic environment remains stable. Thereby, the Board of Directors initiated essential steps to create optimum conditions for the Vifor Pharma and Galenica Santé Business units to be able to continue to develop in a focused and sustainable way.

Strategy Vifor Pharma

Vifor Pharma

Objective: a stand-alone specialty pharma company

Strategy Galenica Santé

Galenica Santé

Objective: building on current strengths in a targeted manner


Galenica Ltd.

Untermattweg 8
CH-3027 Bern

+41 58 852 81 11
+41 58 852 81 12

Send link

Send as link